Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Non Operating Income (2020 - 2025)

Bioventus (BVS) has disclosed Non Operating Income for 6 consecutive years, with -$26.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income fell 2263.5% year-over-year to -$26.8 million, compared with a TTM value of -$28.3 million through Dec 2025, down 51.82%, and an annual FY2025 reading of -$28.3 million, down 1818.3% over the prior year.
  • Non Operating Income was -$26.8 million for Q4 2025 at Bioventus, down from -$79000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $10.1 million in Q3 2023 and bottomed at -$32.1 million in Q4 2022.
  • Average Non Operating Income over 5 years is -$4.3 million, with a median of -$659000.0 recorded in 2021.
  • Peak annual rise in Non Operating Income hit 556.56% in 2022, while the deepest fall reached 8130.0% in 2022.
  • Year by year, Non Operating Income stood at $400000.0 in 2021, then crashed by 8130.0% to -$32.1 million in 2022, then skyrocketed by 102.21% to $709000.0 in 2023, then surged by 75.04% to $1.2 million in 2024, then tumbled by 2263.5% to -$26.8 million in 2025.
  • Business Quant data shows Non Operating Income for BVS at -$26.8 million in Q4 2025, -$79000.0 in Q3 2025, and -$561000.0 in Q2 2025.